May 8 (Reuters) - Prometic Life Sciences Inc PLI.TO :
* Prometic Life Sciences Inc - plasminogen administration shown to reduce acute lung injury ("ali") in an acute pancreatitis model
* Prometic Life Sciences Inc - PBI-4050 is safe and well tolerated and shows evidence of benefit in idiopathic pulmonary fibrosis Source text for Eikon: ID:nPn22ZKS7a Further company coverage: PLI.TO